ArticleAntimicrobial agents and chemotherapy2020

Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial.

Sandra McCurdy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.